Renal failure due to primary amyloidosis
a case report and literature review
Keywords:
Amyloidosis, Amyloid, Kidney failure, Nephrotic syndrome, Congo redAbstract
CONTEXT: Primary amyloidosis, also known as AL amyloidosis, is commonly caused by clonal expansion of plasma cells in the bone marrow, thereby segregating light chains of clonal immunoglobulin that settle in tissues in the form of insoluble amyloid fibrils. The aim of this study was to report a case of primary amyloidosis with renal failure, diagnosed in Hospital São João, Porto, Portugal, focusing on the diagnostic difficulties and presenting a literature review. CASE REPORT: A 68-year-old Caucasian man was admitted to the Internal Medicine Department of the hospital with a condition of anasarca and nephrotic syndrome. After performing a renal biopsy that tested positive using Congo red and immunohistochemistry, lambda light chain amyloidosis was diagnosed. This evolved into terminal renal disease, which led to hemodialysis and several episodes of urinary and catheter infections. He was started on chemotherapy, consisting of bortezomib 0.7 mg/m2 and dexamethasone 40 mg in six cycles. This led to clinical improvement, stabilization of the illness and good tolerance of the treatment. CONCLUSION: Amyloidosis is a rare entity that is difficult to diagnose. This is because of the unspecific early clinical manifestations of the disease. The hypothesis of amyloidosis is only considered when specific organ failure occurs. This case consisted of primary amyloidosis with involvement of the kidneys as an initial presentation of the disease and its difficulties were shown, going from the clinical approach to the final diagnosis.
Downloads
References
Braunwald E, Hauser S, Jameson J, et al. Harrison’s principles of internal medicine. 17th ed. New York: McGraw-Hill; 2008. p. 2145-9.
D’Sa S, Abildgaard N, Tighe J, Shaw P, Hall-Craggs M. Guidelines for the use of imaging in the management of myeloma. Br J Haematol. 2007;137(1):49-63.
Kyle RA, Gertz MA. Primary systemic amyloidosis: clinical and laboratory features in 474 cases. Semin Hematol. 1995;32(1):45-59.
Lachmann HJ, Booth DR, Booth SE, et al. Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis. N Eng J Med. 2002;346(23):1786-91.
Alambert CO, Sarpi MO, Dedivitis RA, et al. Macroglossia como primeira manifestação clíni- ca da amiloidose primária [Macroglossia as initial clinical manifestation of primary amyloi- dosis]. Rev Bras Reumatol. 2007;47(1):76-9.
Melo LV. Amiloidose sistêmica associada a mieloma múltiplo: relato de caso com amiloido- se cutânea exuberante. An Bras Dermatol. 1997;72(2):151-4.
Sipe JD, Cohen AS. Review: history of the amyloid fibril. J Struct Biol. 2000;130(2-3): 88-98.
Duston MA, Skinner M, Shirahama T, Cohen AS. Diagnosis of amyloidosis by abdominal fat aspiration. Analysis of four years’ experience. Am J Med. 1987;82(3):412-4.
Sezer O, Eucker J, Jakob C, Possinger K. Diagnosis and treatment of AL amyloidosis. Clin Nephrol. 2000;53(6):417-23.
Lachmann HJ, Goodman HJ, Gilbertson JA, et al. Natural history and outcome in systemic AA amyloidosis. N Engl J Med. 2007;356(23):2361-71.
Katzmann JA, Dispenzieri A, Abraham RS, Kyle RA. Performance of free light chain assays in clinical practice. Blood (ASH Annual Meeting Abstracts). 2004;104:Abstract 757. Available from: http://abstracts.hematologylibrary.org/cgi/content/abstract/104/11/757. Acces- sed in 2011 (Jan 24).
Albright R, Brensilver J, Cortell S. Proteinuria in congestive heart failure. Am J Nephrol. 1983;3(5):272-5.
Falk RH, Skinner M. The systemic amyloidoses: an overview. Adv Intern Med. 2000;45: 107-37.
Hachulla E, Grateau G. Diagnostic tools for amyloidosis. Joint Bone Spine. 2002;69(6): 538-45.
Rajkumar SV, Gertz MA. Advances in the treatment of amyloidosis. N Engl J Med. 2007;356(23):2413-5.
Goodman HJ, Gillmore JD, Lachmann HJ, et al. Outcome of autologous stem cell transplan- tation for AL amyloidosis in the UK. Br J Haematol. 2006;134(4):417-25.
Mazuecos A, Araque A, Sánchez R, et al. Systemic amyloidosis secondary to pyonephrosis. Resolution after nephrectomy. Nephrol Dial Transplant. 1996;11(5):875-8.
Pozzi C, Locatelli F. The patient with insidious chronic renal failure and the patient with the nephrotic syndrome--two manifestations of a protean and not so rare disease. Nephrol Dial Transplant. 1996;11(9):1876-80.
Snanoudj R, Beaudreuil S, Arzouk N, et al. Recovery from pure red cell aplasia caused by anti- erythropoietin antibodies after kidney transplantation. Am J Transplant. 2004;4(2):274-7.
Gatica MA, Bertin CP, Tagle VR. Síndrome de lisis de glóbulos blancos después de un trasplante autólogo de células troncales hematopoyéticas en el tratamiento de la amiloidosis AL renal: Caso clínico [White blood cell lysis syndrome after autologous peripheral blood stem cell transplantation in the treatment of renal AL amyloidosis: Case report]. Rev Méd Chile. 2006;134(6):763-6.
